First human tests for new pill halted after safety check
NCT ID NCT03977974
Summary
This was an early-stage study to check the safety and side effects of a new oral drug called LY3526318 in healthy people. It also measured how the drug moves through and is processed by the body. The study was terminated after enrolling 76 participants and did not aim to treat any specific disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
PRA Health Sciences
Groningen, 9728, Netherlands
Conditions
Explore the condition pages connected to this study.